Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly
Abstract
The safety and immunogenicity of purified fusion protein (PFP-2) respiratory syncytial virus (RSV) vaccine was evaluated in an open label study in 37 frail institutionalized persons over age 65. Vaccination was well tolerated without significant side-effects. Thirty-six of 37 volunteers completed th …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
safety
research support
non-u.s. gov't
female
male
aged
80 and over
Antibodies
viral / blood
neutralization tests
respiratory syncytial virus infections / immunology
respiratory syncytial virus infections / prevention & control*
viral fusion proteins / immunology
vaccines
immunoglobulin g / blood
chronic disease
human / immunology*
respiratory syncytial virus
viral vaccines / adverse effects
respiratory tract infections / immunology
a r falsey
e e walsh
pmid:9269057
doi:10.1016/s0264-410x(97)00002-9
homes for the aged
nursing homes
respiratory tract infections / prevention & control*
synthetic / pharmacology*
viral vaccines / pharmacology*
Access
Citation
ID:
114673
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114673
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
